Issue 7/2024
Daskalov, V., Kermedchieva, R.
SOBAL «Pentagram» – Sofia
Objective: The aim of the present study was to present the efficacy of the PreserFlo MicroShunt (Santen, Osaka, Japan) after surgical treatment in patients with open-angle glaucoma.
Material and Methods: A retrospective analysis of patients with open-angle glaucoma after microinvasive glaucoma surgery (MIBS) with PreserFlo implantation with MMC 0.4 mg/mL administered over 2 min intraoperatively was performed. A total of 43 patients (50 eyes) were included, of which 22 men (%) and 21 women (%). The average age is 65.26 years (32 – 91 years). The implantations were carried out in the period 2020-2023. with a follow-up period of two years. Before surgery, all patients had uncompensated IOP on hypotensive therapy. IOP values <= 18mm/Hg without or with additional drug therapy were accepted as successful surgery and function. The operative interventions of all patients were performed by one surgeon at SOBAL “Pentagram”.
Results: After the performed procedure, we reported the effectiveness of the PreserFlo microimplant in reducing IOP, with 82% of the values being